Rockefeller Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.61M | Buy |
115,356
+24,853
| +27% | +$1.21M | 0.01% | 755 |
|
|
2025
Q1 | $3.08M | Buy |
90,503
+931
| +1% | +$31.7K | 0.01% | 881 |
|
|
2024
Q4 | $3.53M | Sell |
89,572
-3,295
| -4% | -$130K | 0.01% | 830 |
|
|
2024
Q3 | $4.36M | Sell |
92,867
-1,160
| -1% | -$54.5K | 0.01% | 751 |
|
|
2024
Q2 | $5.08M | Buy |
94,027
+14,907
| +19% | +$805K | 0.01% | 681 |
|
|
2024
Q1 | $5.39M | Sell |
79,120
-975
| -1% | -$66.5K | 0.02% | 671 |
|
|
2023
Q4 | $5.01M | Buy |
80,095
+5,621
| +8% | +$352K | 0.02% | 634 |
|
|
2023
Q3 | $3.38M | Buy |
74,474
+916
| +1% | +$41.6K | 0.01% | 679 |
|
|
2023
Q2 | $4.13M | Sell |
73,558
-3,618
| -5% | -$203K | 0.02% | 637 |
|
|
2023
Q1 | $3.49M | Sell |
77,176
-3,590
| -4% | -$162K | 0.02% | 646 |
|
|
2022
Q4 | $3.28M | Sell |
80,766
-14,666
| -15% | -$596K | 0.02% | 611 |
|
|
2022
Q3 | $6.24M | Buy |
95,432
+80,146
| +524% | +$5.24M | 0.03% | 476 |
|
|
2022
Q2 | $928K | Sell |
15,286
-8,432
| -36% | -$512K | ﹤0.01% | 1021 |
|
|
2022
Q1 | $1.49M | Buy |
23,718
+56
| +0.2% | +$3.51K | 0.01% | 913 |
|
|
2021
Q4 | $1.79M | Buy |
23,662
+6,569
| +38% | +$497K | 0.01% | 838 |
|
|
2021
Q3 | $1.91M | Buy |
17,093
+13,550
| +382% | +$1.52M | 0.01% | 770 |
|
|
2021
Q2 | $573K | Sell |
3,543
-1,053
| -23% | -$170K | ﹤0.01% | 1147 |
|
|
2021
Q1 | $560K | Sell |
4,596
-1,242
| -21% | -$151K | ﹤0.01% | 983 |
|
|
2020
Q4 | $893K | Buy |
5,838
+1,321
| +29% | +$202K | 0.01% | 721 |
|
|
2020
Q3 | $377K | Buy |
4,517
+802
| +22% | +$66.9K | ﹤0.01% | 864 |
|
|
2020
Q2 | $273K | Buy |
3,715
+2,000
| +117% | +$147K | ﹤0.01% | 870 |
|
|
2020
Q1 | $72K | Sell |
1,715
-132
| -7% | -$5.54K | ﹤0.01% | 1125 |
|
|
2019
Q4 | $112K | Sell |
1,847
-25
| -1% | -$1.52K | ﹤0.01% | 925 |
|
|
2019
Q3 | $77K | Sell |
1,872
-107
| -5% | -$4.4K | ﹤0.01% | 856 |
|
|
2019
Q2 | $93K | Hold |
1,979
| – | – | ﹤0.01% | 704 |
|
|
2019
Q1 | $71K | Hold |
1,979
| – | – | ﹤0.01% | 836 |
|
|
2018
Q4 | $57K | Hold |
1,979
| – | – | ﹤0.01% | 506 |
|
|
2018
Q3 | $88K | Hold |
1,979
| – | – | ﹤0.01% | 401 |
|
|
2018
Q2 | $116K | Buy |
+1,979
| New | +$116K | ﹤0.01% | 372 |
|